Cancer Research UK is the world’s leading cancer charity dedicated to saving lives through research, committed to bringing forward the day that all cancers are cured. The charity’s Centre for Drug Development (CDD) sits at the heart of their innovation network of Experimental Cancer Medicine Centres. Rik van Mol at Veeva and Stephen Nabarro at Cancer Research UK shows how the CDD has prioritised TMF modernisation to accelerate trial delivery and ultimately help bring new therapies to market faster.